国际肺癌研究协会肺癌分期项目:对即将发布的第九版肺癌TNM分类中N描述符的修订建议
国际肺癌研究协会汇集45032例临床N和35009例病理N的NSCLC患者数据,用Kaplan-Meier法和Cox回归分析评估预后分组。结果显示当前N0-N3描述符反映预后不同的组,且单站N2(N2a)预后优于多站N2(N2b),差异在各亚组中一致。结论建议维持当前N描述符,并为N2新增N2a和N2b亚描述符。
要点
- 当前临床N和病理N的N0至N3描述符反映预后不同的组。
- 单站N2(N2a)预后优于多站N2(N2b),临床和病理分类中均如此。
- 建议维持当前N描述符,并为N2新增N2a和N2b亚描述符。
核心结论
- 建议维持当前N描述符,并为N2新增单站受累(N2a)和多站受累(N2b)亚描述符。
研究设计与样本
- 国际肺癌研究协会汇集NSCLC患者数据,临床N状态45032例、病理N状态35009例,含解剖位置和个体站级识别信息。
- 生存用Kaplan-Meier法计算,预后分组用Cox回归分析评估。
主要发现
- 临床N和病理N分类中,当前N0至N3描述符均反映预后不同的组。
- 临床和病理分类中,单站N2受累(N2a)预后优于多站N2受累(N2b),所有相邻淋巴结亚组间差异均高度显著。
- N2a与N2b的预后差异在切除状态、组织学类型、T分类和地理区域中均稳健一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The accurate assessment of nodal (N) status is crucial to the management and prognostication of nonmetastatic NSCLC. We sought to determine whether the current N descriptors should be maintained or revised for the upcoming ninth edition of the international TNM lung cancer staging system. METHODS: Data were assembled by the International Association for the Study of Lung Cancer on patients with NSCLC, detailing both clinical and pathologic N status, with information about anatomical location and individual station-level identification. Survival was calculated by the Kaplan-Meier method and prognostic groups were assessed by a Cox regression analysis. RESULTS: Data for clinical N and pathologic N status were available in 45,032 and 35,009 patients, respectively. The current N0 to N3 descriptors for both clinical N and pathologic N categories reflect prognostically distinct groups. Furthermore, single-station N2 involvement (N2a) exhibited a better prognosis than multistation N2 involvement (N2b) in both clinical and pathologic classifications, and the differences between all neighboring nodal subcategories were highly significant. The prognostic differences between N2a and N2b were robust and consistent across resection status, histologic type, T category, and geographic region. CONCLUSIONS: The current N descriptors should be maintained, with the addition of new subdescriptors to N2 for single-station involvement (N2a) and multiple-station involvement (N2b).
引用
- Huang J, Osarogiagbon RU, Giroux DJ, et al. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2023. PMID: 37866624. doi:10.1016/j.jtho.2023.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。